215 related articles for article (PubMed ID: 7513186)
1. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients.
McSherry C; Hertz MI; Jackson AM; Butters K; Diko M; Matas AJ; Bolman RM; Reinsmoen NL
Clin Transplant; 1995 Dec; 9(6):442-9. PubMed ID: 8645886
[TBL] [Abstract][Full Text] [Related]
3. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
Reinsmoen NL; Matas AJ
Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
[TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
5. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
6. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
7. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
8. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
9. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
10. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
Reinsmoen NL; Nelson K; Zeevi A
Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
[TBL] [Abstract][Full Text] [Related]
11. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation.
Wisser W; Wekerle T; Zlabinger G; Senbaclavaci O; Zuckermann A; Klepetko W; Wolner E
J Heart Lung Transplant; 1996 Dec; 15(12):1209-16. PubMed ID: 8981206
[TBL] [Abstract][Full Text] [Related]
12. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
13. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
14. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
[TBL] [Abstract][Full Text] [Related]
15. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients.
Reinsmoen NL; Jackson A; McSherry C; Ninova D; Wiesner RH; Kondo M; Krom RA; Hertz MI; Bolman RM; Matas AJ
Transplantation; 1995 Dec; 60(12):1546-54. PubMed ID: 8545888
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
18. The UNOS renal transplant registry.
Cecka JM
Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
[TBL] [Abstract][Full Text] [Related]
19. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival.
Roberts DH; Wain JC; Chang Y; Ginns LC
J Heart Lung Transplant; 2004 Nov; 23(11):1252-9. PubMed ID: 15539123
[TBL] [Abstract][Full Text] [Related]
20. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients.
Reinsmoen NL; McSherry C; Chavers B; Hertz MI; Matas AJ
Pediatr Nephrol; 1995; 9 Suppl():S35-9. PubMed ID: 7492484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
